Drugs / New Castle Disease Virus
New Castle Disease Virus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01174537 | Jul 2011 | glioblastoma, neuroblastoma, sarcoma | Hadassah Medical Organization | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | New Castle Disease Virus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01174537 ↗ |
| Known as | NDV | “New Castle Virus (NDV) has a long history as a broad system oncolytic that can destroy tumor cells and stimulate the immune system.” NCT01174537 ↗ |
| Known as | New Castle Virus | “New Castle Virus (NDV) has a long history as a broad system oncolytic that can destroy tumor cells and stimulate the immune system.” NCT01174537 ↗ |